Nurix Therapeutics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$3,969,303
19 notices · 208,789 sh
Oct 2025 to Oct 2026
Reported ·
$2,443,318
25 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
13 of 25 reported sales carry the 10b5-1 box. Together they are 0.14% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-02CHRISTINE RING, Chief Legal Officer$135,045
2026-09-02CHRISTINE RING, Chief Legal Officer$150,693
2026-08-05GWENN HANSEN, Chief Scientific Officer$215,099
2026-08-04GWENN M HANSEN, Chief Scientific Officer$95,457
2026-08-04JOHANNES VAN HOUTE, Chief Financial Officer$110,550
2026-08-03CHRISTINE RING, Chief Legal Officer$385,031
2026-07-02CHRISTINE RING, Chief Legal Officer$263,201
2026-06-25CHRISTINE RING, Chief Legal Officer$558,446
Form 4, 2026-06-25: sold 28,935 at $20.06 Form 4 ↗
2026-06-25GWENN M HANSEN, Chief Scientific Officer$104,104
Form 4, 2026-06-25: sold 5,394 at $20.00 Form 4 ↗
2026-06-02CHRISTINE RING, Chief Legal Officer$141,694
Form 4, 2026-06-02: sold 8,148 at $16.60 Form 4 ↗
2026-05-05JOHANNES VAN HOUTE, Chief Financial Officer$237,951
Form 4, 2026-05-05: sold 14,055 at $16.60 Form 4 ↗
2026-05-04CHRISTINE RING, Chief Legal Officer$136,968
Form 4, 2026-05-04: sold 8,148 at $16.96 Form 4 ↗
2026-05-01CHRISTINE RING, Chief Legal Officer$90,080
Form 4, 2026-05-01: sold 5,394 at $16.76 Form 4 ↗
2026-04-02CHRISTINE RING, Chief Legal Officer$126,131
Form 4, 2026-04-02: sold 8,148 at $15.24 Form 4 ↗
2026-03-02CHRISTINE RING, Chief Legal Officer$130,124
Form 4, 2026-03-02: sold 8,148 at $15.44 Form 4 ↗
2026-02-09CHRISTINE RING, Chief Legal Officer$240,298
Form 4, 2026-02-09: sold 14,261 at $16.66 Form 4 ↗
2025-12-18CHRISTINE RING, Chief Legal Officer$136,939
Form 4, 2025-12-18: sold 3,760 at $17.91 Form 4 ↗
2025-11-24CHRISTINE RING, Chief Legal Officer$630,176
Form 4, 2025-11-24: sold 37,600 at $17.07 Form 4 ↗